These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 22072254)

  • 1. Lack of an association between autoimmune pancreatitis and Varicella Zoster Virus.
    Patel NC; Palmer WC; Krishna M; Lewis MD; Wallace MB
    JOP; 2011 Nov; 12(6):614-5. PubMed ID: 22072254
    [No Abstract]   [Full Text] [Related]  

  • 2. Vaccine Oka varicella-zoster virus genotypes are monomorphic in single vesicles and polymorphic in respiratory tract secretions.
    Quinlivan MA; Gershon AA; Nichols RA; La Russa P; Steinberg SP; Breuer J
    J Infect Dis; 2006 Apr; 193(7):927-30. PubMed ID: 16518753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and therapeutic aspects of varicella-zoster virus infection.
    Quinlivan M; Breuer J
    Expert Rev Mol Med; 2005 Aug; 7(15):1-24. PubMed ID: 16098235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rashes occurring after immunization with a mixture of viruses in the Oka vaccine are derived from single clones of virus.
    Quinlivan ML; Gershon AA; Steinberg SP; Breuer J
    J Infect Dis; 2004 Aug; 190(4):793-6. PubMed ID: 15272408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Varicella zoster virus: vaccination and implications in children with renal failure.
    Fadrowski JJ; Furth SL
    Expert Rev Vaccines; 2004 Jun; 3(3):291-8. PubMed ID: 15176945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neonatal vaccine-strain varicella-zoster virus infection 22 days after maternal postpartum vaccination.
    Kluthe M; Herrera A; Blanca H; Leung J; Bialek SR; Schmid DS
    Pediatr Infect Dis J; 2012 Sep; 31(9):977-9. PubMed ID: 22572750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The parental strain of the attenuated virus (vOka) used in the varicella vaccine is circulating in China: implications for vaccine surveillance.
    Gan L; Wang M; Liu J; Yang S; Chen J
    Jpn J Infect Dis; 2010 Mar; 63(2):141-3. PubMed ID: 20332581
    [No Abstract]   [Full Text] [Related]  

  • 8. Laboratory characteristics of suspected herpes zoster in vaccinated children.
    Chun C; Weinmann S; Riedlinger K; Mullooly JP; Houston H; Schmid DS; Seward JF
    Pediatr Infect Dis J; 2011 Aug; 30(8):719-21. PubMed ID: 21346684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herpes zoster with skin lesions and meningitis caused by 2 different genotypes of the Oka varicella-zoster virus vaccine.
    Levin MJ; DeBiasi RL; Bostik V; Schmid DS
    J Infect Dis; 2008 Nov; 198(10):1444-7. PubMed ID: 18826373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evaluation of single nucleotide polymorphisms used to differentiate vaccine and wild type strains of varicella-zoster virus.
    Quinlivan M; Gershon AA; Steinberg SP; Breuer J
    J Med Virol; 2005 Jan; 75(1):174-80. PubMed ID: 15543576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of vaccination on the epidemiology of varicella zoster virus.
    Edmunds WJ; Brisson M
    J Infect; 2002 May; 44(4):211-9. PubMed ID: 12099726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA sequence analysis of varicella-zoster virus gene 62 from subclinical infections in healthy children immunized with the Oka varicella vaccine.
    Gomi Y; Ozaki T; Nishimura N; Narita A; Suzuki M; Ahn J; Watanabe N; Koyama N; Ushida H; Yasuda N; Nakane K; Funahashi K; Fuke I; Takamizawa A; Ishikawa T; Yamanishi K; Takahashi M
    Vaccine; 2008 Oct; 26(44):5627-32. PubMed ID: 18706951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The safety profile of varicella vaccine: a 10-year review.
    Galea SA; Sweet A; Beninger P; Steinberg SP; Larussa PS; Gershon AA; Sharrar RG
    J Infect Dis; 2008 Mar; 197 Suppl 2():S165-9. PubMed ID: 18419392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different genotype pattern of varicella-zoster virus obtained from patients with varicella and zoster in Germany.
    Sauerbrei A; Wutzler P
    J Med Virol; 2007 Jul; 79(7):1025-31. PubMed ID: 17516537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccine-strain varicella zoster virus causing recurrent herpes zoster in an immunocompetent 2-year-old.
    Ota K; Kim V; Lavi S; Ford-Jones EL; Tipples G; Scolnik D; Tellier R
    Pediatr Infect Dis J; 2008 Sep; 27(9):847-8. PubMed ID: 18664930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Varicella vaccine--are two doses better than one?
    Gershon AA
    N Engl J Med; 2002 Dec; 347(24):1962-3. PubMed ID: 12477947
    [No Abstract]   [Full Text] [Related]  

  • 17. The varicella vaccine.
    Arvin AM
    Curr Clin Top Infect Dis; 1997; 17():110-46. PubMed ID: 9189664
    [No Abstract]   [Full Text] [Related]  

  • 18. A case of varicella caused by co-infection with two different genotypes of varicella-zoster virus.
    Quinlivan M; Sengupta N; Breuer J
    J Clin Virol; 2009 Jan; 44(1):66-9. PubMed ID: 18996045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Varicella zoster virus: natural history and current therapies of varicella and herpes zoster.
    Breuer J; Whitley R
    Herpes; 2007 Sep; 14 Suppl 2():25-9. PubMed ID: 17939892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of varicella vaccine.
    Takahashi M; Asano Y; Kamiya H; Baba K; Ozaki T; Otsuka T; Yamanishi K
    J Infect Dis; 2008 Mar; 197 Suppl 2():S41-4. PubMed ID: 18419406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.